R-568 calcimimetic: AMGN will begin trials

AMGN will complete a Phase II trial with R-568 in late 1997 and

Read the full 136 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE